Kitman Labs, the global enterprise SaaS company delivering the only fully centralized operating system for performance intelligence in elite sports, today announced a new partnership with the United Soccer League (USL) that will see all eight clubs competing in the USL Super League deploy the Performance Medicine Solution in Kitman Labs’ iP: Intelligence Platform.
Now in its inaugural season following an August 2024 launch, the USL Super League is operated by the United Soccer League and marks a new era for women’s professional soccer in North America. Through this league-wide partnership, each club will leverage a centralized and configurable medical operating system that enables the aggregation and activation of all player health data.
The Performance Medicine Solution—one of four core solutions within iP: Intelligence Platform—is the only system natively built to integrate both medical and performance data into a single, comprehensive platform. This will give member clubs a real-time, 360° view of their respective players from a health and readiness perspective while generating insights to improve athlete welfare, reduce injury risk, and drive performance outcomes through actionable intelligence.
Key capabilities powered by Performance Medicine for USL Super League clubs include:
Standardized league-wide medical documentation and data collection – eliminating gaps and inconsistencies while supporting club-level configurability and compliance.
Cross-department collaboration – aligning medical and performance teams to support evidence-based decisions around player health, care, and wellness.
Operational efficiency – enabling practitioners to spend less time on admin and more time on athlete treatment and development.
Comprehensive, consistent datasets – laying the foundation for league-wide research, injury surveillance, and innovation.
All staff, coaches, and practitioners from across the eight Super League clubs will utilize the shared platform as a single source of truth. The resulting analytics will help inform data-led, evidence-based decisions on and off the pitch.
“We have the opportunity to build a cutting-edge data and analytics infrastructure from the ground up—a secure, fully integrated and scalable platform that benefits the league, the clubs, and most importantly, the athletes,” said Amanda Vandersort, USL Super League President. “With this system in place, our medical and performance staff can make better decisions around injury prevention, rehab, return to play, load management, and overall athlete care.”
“We’re proud to partner with the USL Super League in its inaugural season and be part of this defining moment for women’s professional soccer,” said Stephen Smith, CEO and Founder of Kitman Labs. “The league has a clear vision for innovation—prioritizing player health, performance, and longevity. With iP: Intelligence Platform, the USL has the foundation to scale and unify medical data management and analytics, equipping every club with the technology and intelligence needed to make data-informed decisions and elevate athlete care.”
The league’s eight inaugural clubs—Brooklyn FC, Carolina Ascent FC, Dallas Trinity FC, DC Power FC, Fort Lauderdale United FC, Lexington SC, Spokane Zephyr FC, and Tampa Bay Sun FC—are competing for the championship, set to be decided in June.
Kitman Labs has an established track record of working with top leagues, governing bodies, teams, and athletes across 26 countries and multiple sports, including soccer, basketball, rugby, and American football. The company’s technology is currently used by more than 2,000 teams and organizations, including the NFL, NBA, MLS, NWSL, Unrivaled, Premier League, and NCAA.
iP: Intelligence Platform represents the industry’s largest dataset of talent, performance, and medical data, supporting every stage of the athlete lifecycle.